US3149108A - Preparation of derivatives of 1, 4-benzodioxan - Google Patents

Preparation of derivatives of 1, 4-benzodioxan Download PDF

Info

Publication number
US3149108A
US3149108A US148704A US14870461A US3149108A US 3149108 A US3149108 A US 3149108A US 148704 A US148704 A US 148704A US 14870461 A US14870461 A US 14870461A US 3149108 A US3149108 A US 3149108A
Authority
US
United States
Prior art keywords
benzodioxan
yield
refluxing
catechol
ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US148704A
Inventor
Koo John
Leonard Frederick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Corp
Original Assignee
Geigy Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Chemical Corp filed Critical Geigy Chemical Corp
Priority to US148704A priority Critical patent/US3149108A/en
Priority to BE613213A priority patent/BE613213A/en
Priority to ES0274332A priority patent/ES274332A1/en
Priority to ES0274335A priority patent/ES274335A1/en
Application granted granted Critical
Publication of US3149108A publication Critical patent/US3149108A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Definitions

  • This invention relates to a new process for making derivatives of 1,4-benzodioxan and, more specifically, to a process for preparing derivatives of 1,4-benzodioxan compounds which are substituted in their two-position by amino(lower) alkyl moieties.
  • R denotes hydrogen, lower alkyl; aralkylparticularly, benzyl and aryl particularly phenyl; but it may also represent heterocyclic radicals, such as, pyridyl, piperidyl, morpholinyl, etc.;
  • R stands for hydrogen, halogen-particularly, chlorine and bromine; hydroxy; lower alkyl and lower alkoxy;
  • X represents halogen, preferably, chlorine or bromine and n ranges from 0 to 4.
  • lower alkyl as used herein per se and as included in die term lower alkoxy means saturated monovalent aliphatic radicals of the general formula C H wherein n designates an integer of less than six and is inclusive of both straight-chain and branchedchain radicals.
  • the 1,4-benzodioxan compounds referred to above, and particularly, many of their derivatives have been found to possess outstanding pharmacological properties, such as sympatholytic properties [Fourneau et al., Arch. intern. pharmacodynamie, 46, 178 (1933); Bovet et al., Arch. intern. pharmacodynamie, 55, 15 (1937); Goldenberg et al., J. Am. Med. Assoc., 135, 971 (1947)], Central depressant properties (Mills, Abstracts, 132nd Meeting, Am. Chem. Soc., New York, Sept. 1957, 7-0; U.S. Patent 2,906,757 and U.S.
  • 2-amino(lower) alkyl- 1,4-benzodioxan 2-aminomethyl-1,4-benzodioxan, for instance, can be synthesized by the three-step procedure carried out by G. B. Marini-Betolo et al. in Gazz. Chirn. Ital., 83, 144 (1953). Catechol was refluxed with epichlorohydrin to yield l,4-benzodioxan-Z-methanol. This was obtained in 90% yield crude and 60% yield pure.
  • Patent 2,366,102 there is obtained 2-aminomethyl-l,4- benzodioxan. No yield is given for this conversion. But it has been found when following this procedure that this is obtained only in 15% yield from 2-chloromethyl- 1,4-benzodioxan. This last step, in addition to affording only low yields of the desired product, must be carried out under high pressure and is by no means a simple conversion. The overall yield for this three-step process, as described in the literature, is 5.8%
  • 2-aminornethyl-1,4-benzodioxan has also been synthesized in somewhat better yield in three steps in accordance with a method described in Koo et al., J.
  • 3-aminomethyl-2-methyl-1,4-benzodioxan was also synthesized in three steps by Koo et al., J. Org. Chem., 26, 339 (1961) by condensing catechol with ethyl 2,3-dibromobutyrate in the presence of potassium carbonate giving, in 30% yield, ethyl 3-methyl-1,4-benz0dioXan-2- carboxylate. Ammoniation of this ester afforded 3- methyl-1,4-benzodioXan-2-carboxamide in yield. Reduction of the carboxamide with lithium aluminum hydride gave 2-aminomethyl-3-methyl-1,4-benzodioxan in 70% yield.- The overall yield for this process was 16.8%.
  • this method involves reacting catechol or a substituted catechol with an appropriate dihalo alkanoic acid nitrile to produce the corresponding cyano derivative of 1,4-benzodioxan in yields as high as Reduction of the cyano derivative proceeds readily to 2- amino (lower)alkyl 3-substituted or unsubstituted-1,4- benzodioxanin yields as high as 77%.
  • the process of this invention contemplates as first step refluxing for several hours of catechol or a substituted catechol, dissolved in, preferably, dry acetone as inert solvent, with a dibrorno (lower)alkanoic acid Patented Sept.
  • binding agents as potassium hydroxide, sodium carbonate and sodium hydroxide, calcium carbonate and their equivalents may be employed.
  • acetone as inert solvent for the catechol, it is practicable to use such organic solvents as, benzene, toluene, dibutylether, etc., while as diluent for lithium aluminum hydride in addition to ether, also tetrahydrofuran, dioxan, and their equivalents may be employed.
  • the starting materials, substituted or unsubstituted catechols and dibromo(lower)alkanoic acid nitriles are respectively, commercially available or available by synthesis, e.g., according to the following literature references: Moureau, Annales de Chimie et de Physique [7] 2, 189 (2,3-dibromopropionitrile)-; Lespieau, Comptes rendus de lAcademie des Sciences, 137, 262 (3,4-dibromobutyronitrile); Palmer, American Chemical Journal, 11, 91 (2,3-dibromobutyronitrile); etc.
  • benzodioxan which comprises the steps of adding to a solution of a catechol of the formula wherein R is a member selected from the group consisting of hydrogen, chlorine, bromine, hydroxy, lower alkyl and lower alkoxy, in dry acetone, anhydrous potassium carbonate as acid binding agent and a dibromo(lower)a1- kanoic acid nitrile of the formula XOH-R wherein R is selected from the groupconsisting of hydrogen and lower alkyl, benzyl, phenyl, pyridyl, piperidyl and morpholinyl, X is taken from the group consisting of chlorine and bromine, and n has a value of 0 to 4, refluxing the reaction mixture thus obtained for from 18 to 36 hours, recovering and purifying the resulting cyano 1,4- benzodioxan of the formula 2) n N R1 References Cited in the file of this patent Koo et al.: J. Am. Chem. Soc., vol.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

United States Patent 3,149,108 PREPARATION 0F DERIVATIVES 0F 1,4-EENZODIOXAN John Koo, irvington-nn-Hudscn, and Frederick Leonard,
Yonkers, N.Y., assignors to Geigy Chemical Corporation, Greenbnrgh, N.Y., a corporation of Delaware No Drawing. Filed Oct. 30, 1961, Ser. No. 148,704 3 Claims. (Cl. 260-4475) This invention relates to a new process for making derivatives of 1,4-benzodioxan and, more specifically, to a process for preparing derivatives of 1,4-benzodioxan compounds which are substituted in their two-position by amino(lower) alkyl moieties.
The subject process for the synthesis of these 1,4-benzodioxan derivatives may be graphically and briefly illustrated by the following equations:
o (cannon R1 (0H2)IION (CH2)m-HNH2 L'AlH R1 In these equations R denotes hydrogen, lower alkyl; aralkylparticularly, benzyl and aryl particularly phenyl; but it may also represent heterocyclic radicals, such as, pyridyl, piperidyl, morpholinyl, etc.;
R stands for hydrogen, halogen-particularly, chlorine and bromine; hydroxy; lower alkyl and lower alkoxy;
X represents halogen, preferably, chlorine or bromine and n ranges from 0 to 4.
The term lower alkyl as used herein per se and as included in die term lower alkoxy means saturated monovalent aliphatic radicals of the general formula C H wherein n designates an integer of less than six and is inclusive of both straight-chain and branchedchain radicals.
The 1,4-benzodioxan compounds, referred to above, and particularly, many of their derivatives have been found to possess outstanding pharmacological properties, such as sympatholytic properties [Fourneau et al., Arch. intern. pharmacodynamie, 46, 178 (1933); Bovet et al., Arch. intern. pharmacodynamie, 55, 15 (1937); Goldenberg et al., J. Am. Med. Assoc., 135, 971 (1947)], Central depressant properties (Mills, Abstracts, 132nd Meeting, Am. Chem. Soc., New York, Sept. 1957, 7-0; U.S. Patent 2,906,757 and U.S. Patent 2,922,744), and adrenergic Ifcking properties [Rossi et al., J. Am. Pharm. Assoc., 46?. 472 (1957) and ibid. 48, 409 (1959)].
Many of these pharmaceutical agents have been prepared by using as starting material 2-amino(lower) alkyl- 1,4-benzodioxan. 2-aminomethyl-1,4-benzodioxan, for instance, can be synthesized by the three-step procedure carried out by G. B. Marini-Betolo et al. in Gazz. Chirn. Ital., 83, 144 (1953). Catechol was refluxed with epichlorohydrin to yield l,4-benzodioxan-Z-methanol. This was obtained in 90% yield crude and 60% yield pure. On treatment with thionyl chloride, l,4-benzodioxan-2- methanol was allegedly converted in 90% yield to 2- chloromethyl-1,4-benzodioxan. However, when this conversion method was repeated, the yield proved to be no better than 46% of pure material. Upon treating 2- nitrile in the presence of potassium carbonate as acidwith alcoholic or gaseous ammonia as described in U.S.
Patent 2,366,102, there is obtained 2-aminomethyl-l,4- benzodioxan. No yield is given for this conversion. But it has been found when following this procedure that this is obtained only in 15% yield from 2-chloromethyl- 1,4-benzodioxan. This last step, in addition to affording only low yields of the desired product, must be carried out under high pressure and is by no means a simple conversion. The overall yield for this three-step process, as described in the literature, is 5.8%
2-aminornethyl-1,4-benzodioxan has also been synthesized in somewhat better yield in three steps in accordance with a method described in Koo et al., J.
Am. Chem. Soc., 77, 5373 (1955) and Koo, .T. Organic Chemistry, 26, 339 (1961) as follows: Catechol was condensed with ethyl 2,3-dibromopropionate in the presence of potassium carbonate, giving ethyl 1,4-benzodioxan-Z-carboxylate in a yield of 76%. Ammoniation of this afforded 1,4-benzodioXan-2-carboxamide in 94% yield. Reduction of the carboxamide with lithium aluminum hydride proceeded in 82% yield to the desired product. The overallyield for this process was 58%.
3-aminomethyl-2-methyl-1,4-benzodioxan was also synthesized in three steps by Koo et al., J. Org. Chem., 26, 339 (1961) by condensing catechol with ethyl 2,3-dibromobutyrate in the presence of potassium carbonate giving, in 30% yield, ethyl 3-methyl-1,4-benz0dioXan-2- carboxylate. Ammoniation of this ester afforded 3- methyl-1,4-benzodioXan-2-carboxamide in yield. Reduction of the carboxamide with lithium aluminum hydride gave 2-aminomethyl-3-methyl-1,4-benzodioxan in 70% yield.- The overall yield for this process was 16.8%.
Derivatives of 2-amino(lower)alkyl-l,4-benzodioxan have heretofore also been prepared from dilferent intermediates, but they could be synthesized more economically by employing 2-amino(lower)alkyl-l,4-benzodioxan steps giving surprisingly and unexpectedly overall yields as high or higher than those which have heretofore been obtained and reported for the older three-step processes. As illustrated above, this method involves reacting catechol or a substituted catechol with an appropriate dihalo alkanoic acid nitrile to produce the corresponding cyano derivative of 1,4-benzodioxan in yields as high as Reduction of the cyano derivative proceeds readily to 2- amino (lower)alkyl 3-substituted or unsubstituted-1,4- benzodioxanin yields as high as 77%. The combined yield for the two-step procedure for, e.g., Z-aminomethyl- 3-methyl-1,4-benzodioxan is 42%compared with 16.8% by the best procedure described in the literature and for 2- aminomethyl-1,4-benzodioxan is essentially the same as that previously reported in the best literature process, i.e., 54%-compared with 58%. It is thus clear that the present process affords Z-amino (lower) alkyl-3-substituted or unsubstituted 1;4-benzodioxan by a simpler and more direct process than those reported in the'literature in yields equal to or better than the yields previously re-' ported in the literature.
More specifically, the process of this invention contemplates as first step refluxing for several hours of catechol or a substituted catechol, dissolved in, preferably, dry acetone as inert solvent, with a dibrorno (lower)alkanoic acid Patented Sept. 15, 1964 binding agent to produce a 2-cyano-3-substituted or unsubstituted-1,4-benzodioxan or a 2-cyano(lower)alkyl-3- substituted or unsubstituted-1,4-benzodioxan as intermediate, and as second step refluxing for several hours this intermediate with lithium aluminum hydride, suspended in ether, to produce the desired 2-arnino(l'ower) alkyl-3- substituted or unsubstituted-1,4-benzodioxan.
In addition to potassium carbonate, such other acid.
binding agents as potassium hydroxide, sodium carbonate and sodium hydroxide, calcium carbonate and their equivalents may be employed. In fact, it is possible to use any basic compound that is sufl'iciently alkaline to bind hydrohalogenic acid set free during the reaction.
As equivalents for acetone as inert solvent for the catechol, it is practicable to use such organic solvents as, benzene, toluene, dibutylether, etc., while as diluent for lithium aluminum hydride in addition to ether, also tetrahydrofuran, dioxan, and their equivalents may be employed.
It is further apparent to men skilled in the art that the range of practicable equivalents is wider than explicitly circumscribed hereinabove. Therefore, any and all such practicable equivalents are within the scope of this invention.
The starting materials, substituted or unsubstituted catechols and dibromo(lower)alkanoic acid nitriles are respectively, commercially available or available by synthesis, e.g., according to the following literature references: Moureau, Annales de Chimie et de Physique [7] 2, 189 (2,3-dibromopropionitrile)-; Lespieau, Comptes rendus de lAcademie des Sciences, 137, 262 (3,4-dibromobutyronitrile); Palmer, American Chemical Journal, 11, 91 (2,3-dibromobutyronitrile); etc.
This new procedure may further be exemplified more specifically by the following examples wherein the temperatures are given in degrees Centigrade. It is to be understood, however, that the examples are illustrative of the compounds which may be prepared in accordance with the inventive concept and of the method for their synthesis and are not to be construed as limiting the invention to the particular compounds or methods specifically described.
' EXAMPLE I 2-A minomethyl-I ,4-Benzodi0xarz (A) Z-eyano-I,4-benzodioxan.To a solution of 51.7 g. (0.47 mole) of catechol in 250 ml. of dry acetone was added 34.5 g. (0.25 mole) of anhydrous potassium carbonate and then dropwise with stirring and gentle refluxing, 25.0 g. of 2,3-dibromopropionitrile. Another 34.5 g. of potassium carbonate and 25.0 g. of the 2,3-dibromopropionitrile was added similarly, and this was repeated twice more, using altogether 138 g. of potassium carbonate and 100.0 g. of 2,3-dibromopropionitrile. Stirring and refluxing was continued for 20 hours. The solution was then cooled and the solid potassium bromide filtered oif. The cake was washed with acetone and the filtrate concentrated to a dark oil which was extracted into ether and washed with water and sodium bicarbonate solution. The ethereal solution was dried over anhydrous magnesium sulfate and concentrated to 74.9 g. (99%) of an amber oil. The oil was distilled to give 53.1 g. (70%) of 2- cyano-1,4-benzodioxan; B.P. 116119/0.15 mm; 11 1.5443.
(B) 2 aminomethyl -1,4-benzodioxan.-To 14 g. of lithium aluminum hydride in 500 ml. ether was added dropwise 48.3 g. of 2-cyano-1,4-benzodioxan with stirring and refluxing for 12 hours. The mixture'was decomposed first with cold water and then with 300 ml. of 20% sodium potassium tartrate solution. The ether solution was dried and evaporated. The residue was distilled at 92- 94 0.3 mm.; 11 1.5554. The yield of the desired product as colorless oil was 38.1 g. (77%). 1. K00, J. Org. Chem. 26, 339 (1961) reported B.P. 8283/0.75 mm. and 11 1.5554. g
4 EXAMPLE n 2-A minoethyl-I,4-Benz0di0xan (A) Z-cyarzomethyl-I,4-benzodioxan.To a solution of 110.0 g. (1.0 mole) of'catechol in 800 ml. of dry acetone was added first 114.0 g. (0.826 mole) of anhydrous potassium carbonate and then, dropwise with stirring and gentle refluxing, 62.5 g. (0.275 mole) of 3,4-dibromobutyronitrile. Another 114.0 g. of potassium refluxing was continued for 18 hours.
carbonate and 62.5 g. of the 3,4-dibromobutyronitrile was i terial was further purified to a white solid which melted at 65-66" after recrystallization from isopropyl alcohol.
(B) Z-aminoethyl-l,4-benz0ai0xan. -T0 14 g. of lithium aluminum hydride, suspended in 500 ml. of ether, was added 52.5 g. or" 2-cyanomethyl-1,4-benzodioxan (M.P.
, 55-58) in ether with stirring and refluxing for 12 hours.
The mixture was first decomposed with cold water and then with 300 ml. of 20% sodium potassium tartrate solution. The ether was dried and evaporated. The residue was distilled at 105ll0/0.4 mm. to give 14.2 g. (26%) g of the desired compound as colorless oil; 11 1.5502.
The oil was dissolved in ether and HCl gas was introduced. The colorless salt which separated was recrystallized from ethanol-ether to give a pure product; M.P. 157l59.
EXAMPLE III Z-Amirzomelhyl-3-M ethyl-1 ,4-Benz0di0xan (A) 2-cyan0-3-methyl-I,4-benz0di0xan.-To a solution of 24.2 g. (0.22 moles) of catechol in 100 ml. of dry acetone was added 75.9 g. (0.55 mole) of anhydrous potassium carbonate, then dropwise with stirring and gentle refluxing 50.0 g. (0.22 mole) of 2,3-dibromobutyronitrile. Stirring and refluxing continued for 36 hours. The mixture was then cooled and the salt filtered oif. The cake was washed with acetone and the acetone solution was concentrated to 34.2 g. (98% yield) of an oil which was distilled, yield: 22.0 g. (57%) of a colorless oil; B.P. 9098"7/0.25 mm, n 1.5280.
(B) Z-aminomethyl-3-methyl-1,4-benz0dioxan.-To 10* g. of lithium in 400 ml. of ether was added 25.25 g. of 2- cyano-3-methyl-1,4-benzodioxan with stirring and gentle refluxing for 16 hours. The reaction mixture was decomposed first with cold water and then 20% potassium sodium tartrate solution. The ether layer was separated, washed with cold water, dried and filtered. Evaporation of the ether left an oily residue, which was distilled at 9496/0.1 mm. to give 11.8 g. (44%) of a colorless oil; 11 1.5449.
This application is a continuation-in-part of application Serial Number 85,455, filed January 30, 1961, now aban-- doned.
What is claimed is:
I, X 1. A process which comprises refluxing a catechol of the formula wherein R is a member of the group consisting of hydrogen, chlorine, bromine, hydroxy, lower alkyl and lower alkoxy, with a dihalo(lower)alkanoic acid nitrile of the formula wherein R is selected from the group consisting of hydrogen, lower alkyl, benzyl, phenyl, pyridyl, piperidyl and morpholinyl, X is taken from the group consisting of chlorine and bromine, and n has a value of 0 to 4, in the presence of an acid binding agent selected from the group consisting of a carbonate of alkali metals and alkaline earth metals for from 18 to 36 hours, refluxing the resulting cyano 1,4-benzodioxan obtained of the formula oHnnoN R1 wherein R, R and n are as defined hereinabove, with lithium aluminum hydride suspended in an inert diluent for from 12 to 16 hours and recovering the desired 2- amino(lower) alkyl-1,4-benzodioxan.
3. A process for preparing 2-amino(lower)alkyl1,4-
benzodioxan which comprises the steps of adding to a solution of a catechol of the formula wherein R is a member selected from the group consisting of hydrogen, chlorine, bromine, hydroxy, lower alkyl and lower alkoxy, in dry acetone, anhydrous potassium carbonate as acid binding agent and a dibromo(lower)a1- kanoic acid nitrile of the formula XOH-R wherein R is selected from the groupconsisting of hydrogen and lower alkyl, benzyl, phenyl, pyridyl, piperidyl and morpholinyl, X is taken from the group consisting of chlorine and bromine, and n has a value of 0 to 4, refluxing the reaction mixture thus obtained for from 18 to 36 hours, recovering and purifying the resulting cyano 1,4- benzodioxan of the formula 2) n N R1 References Cited in the file of this patent Koo et al.: J. Am. Chem. Soc., vol. 77, pages 5373 Koo: J. Org. Chemistry, vol. 26, page 339 (i961).
UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No 3, 149, 108 September '15 1964 John K00 etv aln It is hereby certified that erroreppears in the above numbered patent requiring correction and that the said Letters Patent should read. as,
corrected below.
Column 1, lines 18 to 22, first equatiom for thaeportioh of the equation reading:
read
- .I YJZHR X-GHR same column 1, lines 25 to 3O, the last structure upper right-hand portion reading;
-(CH2) 1NH2 read 2 n+1 2 Signed and sealed this 12th day of January 1965;
(SEAL) Attest:
EDWARDJQ BRENNER Commissioner of Patents ERNEST W, SWIDER Attesting Officer

Claims (1)

1. A PROCESS WHICH COMPRISES REFLUXING A CATECHOL OF THE FORMULA
US148704A 1961-01-30 1961-10-30 Preparation of derivatives of 1, 4-benzodioxan Expired - Lifetime US3149108A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US148704A US3149108A (en) 1961-10-30 1961-10-30 Preparation of derivatives of 1, 4-benzodioxan
BE613213A BE613213A (en) 1961-01-30 1962-01-29 New 1.4-benzodioxanes and their preparation
ES0274332A ES274332A1 (en) 1961-10-30 1962-01-29 Preparation of derivatives of 1, 4-benzodioxan
ES0274335A ES274335A1 (en) 1961-10-30 1962-01-29 Preparation of derivatives of 1, 4-benzodioxan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US148704A US3149108A (en) 1961-10-30 1961-10-30 Preparation of derivatives of 1, 4-benzodioxan

Publications (1)

Publication Number Publication Date
US3149108A true US3149108A (en) 1964-09-15

Family

ID=22526973

Family Applications (1)

Application Number Title Priority Date Filing Date
US148704A Expired - Lifetime US3149108A (en) 1961-01-30 1961-10-30 Preparation of derivatives of 1, 4-benzodioxan

Country Status (2)

Country Link
US (1) US3149108A (en)
ES (2) ES274335A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
US4056540A (en) * 1974-01-01 1977-11-01 Bristol-Myers Company 4-Phenyl-1,3-benzodioxans
US4129655A (en) * 1976-04-26 1978-12-12 Ciba-Geigy Corporation Neuroleptic 2-piperidinoalkyl-1,4-benzodioxans

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056540A (en) * 1974-01-01 1977-11-01 Bristol-Myers Company 4-Phenyl-1,3-benzodioxans
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
US4104396A (en) * 1975-06-23 1978-08-01 Ciba-Geigy Corporation 2-Piperidinoalkyl-1,4-benzodioxans
US4140781A (en) * 1975-06-23 1979-02-20 Ciba-Geigy Corporation Analgesic and neuraleptic 2-piperidinoalkyl-1,4-benzodioxans
US4129655A (en) * 1976-04-26 1978-12-12 Ciba-Geigy Corporation Neuroleptic 2-piperidinoalkyl-1,4-benzodioxans

Also Published As

Publication number Publication date
ES274332A1 (en) 1962-06-01
ES274335A1 (en) 1962-06-01

Similar Documents

Publication Publication Date Title
US5464872A (en) Arylalkyl (thio) amides
US3238224A (en) Production of 6, 8-dithiooctanoyl amides
US3149108A (en) Preparation of derivatives of 1, 4-benzodioxan
US3948896A (en) N-mono(alkoxymethyl) phenobarbitals, process therefor and therapeutic composition and method containing same
JP3216912B2 (en) Method for producing 2-azabicyclo [2.2.1] hept-5-en-3-one
US3101345A (en) 2-hydroxymethyl-8-hydroxy-1,4-benzodioxane
JPS5949221B2 (en) Method for producing 3-acylamino-4-homoisotwistane
JPS6133829B2 (en)
Cooper Stereospecific synthesis of cis-and trans-2-(3, 4, 5-trimethoxyphenyl)-cyclopropylamines
US3484457A (en) Certain spiro butyrolactones
US3261870A (en) 5-halo-2-nitro-benzophenones and processes for their preparation
US4111990A (en) 1-Acetylaminotricyclo [4.3.1.12,5 ] undecane and process for the preparation thereof
US3842086A (en) Process for the preparation of substituted or unsubstituted pyridines
US4054565A (en) Process for preparing N-mono(alkoxymethyl) phenobarbitals
US3886207A (en) Process for producing indan-1-carboxylic acid derivatives
US3657439A (en) 5 - aryloxyatricyclo(3.2.2.0**2 4)nonane - 1-amines in antidepressant compositions and methods
US3308132A (en) 6, 8-dithiooctanoyl amides and intermediates
US3873605A (en) Resolution of an important prostaglandin intermediate
US3751462A (en) Process for preparation of substituted fluoromethanesulfonanilides
SU727144A3 (en) Method of preparing 2-halogenmethyl-1,4-benzodiazepines or their salts
US4087529A (en) Therapeutic composition containing an N-mono (alkoxy-methyl) phenobarbital and a method of treating convulsions therewith
US3683086A (en) Derivatives of acetic acid for the alleviation of hyperlipemia
JPS6197251A (en) Process for producing 3-(2,2-dimethyl-3-alkyl-6-methylenecyclohexyl)acrylonitrile
SU497766A3 (en) Method for producing amino derivatives of 1,2-diphenyl-1,1,2.2-tetrafluoroethane
US4031245A (en) Alkenyl and alkanylamines for treating depression